HOLOGIC INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 53 rows in 2008. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2008-11-13: Reporting owner LAVALLEE ROBERT H; Form 4; Security Non-Qualified Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-11-13: Reporting owner SOLTANI PETER; Form 4; Security Non-Qualified Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-11-13: Reporting owner PEKARSKY JOHN R; Form 4; Security Non-Qualified Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-11-13: Reporting owner Kingsley Stuart A; Form 4; Security Non-Qualified Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2008-11-13 | LAVALLEE ROBERT H Officer (SVP, Chief Accounting Officer) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $14.50 exercise price | 2008-11-17 | |
| 2008-11-13 | SOLTANI PETER Officer (VP, DRC & Breast Imaging) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $14.50 exercise price | 2008-11-17 | |
| 2008-11-13 | PEKARSKY JOHN R Officer (SVP, Sales & Strategic Account) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $14.50 exercise price | 2008-11-17 | |
| 2008-11-13 | Kingsley Stuart A Officer (President, GYN Surgical) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $14.50 exercise price | 2008-11-17 | |
| 2008-11-13 | Doran Howard JR Officer (President, Diagnostic Products) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $14.50 exercise price | 2008-11-17 | |
| 2008-11-13 | Casey Mark J Officer (Sr. VP, General Counsel) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $14.50 exercise price | 2008-11-17 | |
| 2008-11-13 | STEIN JAY A Officer (Chief Technology Officer) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $14.50 exercise price | 2008-11-17 | |
| 2008-11-13 | MUIR GLENN P Director, Officer (Executive VP and CFO) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +196,000 196,000 owned after | $14.50 exercise price | 2008-11-17 | |
| 2008-11-13 | CASCELLA ROBERT Director, Officer (President & COO) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +281,000 281,000 owned after | $14.50 exercise price | 2008-11-17 | |
| 2008-11-13 | CUMMING JOHN W Director, Officer (Chairman & CEO) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +713,000 713,000 owned after | $14.50 exercise price | 2008-11-17 | |
| 2008-11-13 | CUMMING JOHN W Director, Officer (Chairman & CEO) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,000 28,000 owned after | $14.50 exercise price | 2008-11-17 | |
| 2008-05-01 | MUIR GLENN P Officer (Executive VP & CFO) | 4/A | Incentive Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,832 0 owned after | $1.45 exercise price | 2008-05-02 | |
| 2008-05-01 | MUIR GLENN P Officer (Executive VP & CFO) | 4 | Incentive Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +16,832 0 owned after | $1.45 exercise price | 2008-05-02 | |
| 2008-02-06 | MUIR GLENN P Director, Officer (Executive VP and CFO) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 25,000 owned after | $9.50 exercise price | 2008-02-07 | |
| 2008-01-24 | MUIR GLENN P Director, Officer (Executive VP and CFO) | 4 | Incentive Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,000 0 owned after | $3.00 exercise price | 2008-01-28 | |
| 2008-01-17 holding as of filing | Casey Mark J Officer (Sr. VP, General Counsel) | 3 | Incentive Stock Option (right to buy) Derivative · Direct | Holding | $27.77 exercise price | 2008-01-17 | ||
| 2008-01-17 holding as of filing | Casey Mark J Officer (Sr. VP, General Counsel) | 3 | Incentive Stock Option (right to buy) Derivative · Direct | Holding | $31.62 exercise price | 2008-01-17 | ||
| 2008-01-17 holding as of filing | Casey Mark J Officer (Sr. VP, General Counsel) | 3 | Incentive Stock Option (right to buy) Derivative · Direct | Holding | $36.60 exercise price | 2008-01-17 | ||
| 2008-01-17 holding as of filing | Casey Mark J Officer (Sr. VP, General Counsel) | 3 | Incentive Stock Option (right to buy) Derivative · Direct | Holding | $36.93 exercise price | 2008-01-17 | ||
| 2008-01-17 holding as of filing | Casey Mark J Officer (Sr. VP, General Counsel) | 3 | Non-Qualified Stock Option (right to buy) Derivative · Direct | Holding | $36.60 exercise price | 2008-01-17 | ||
| 2008-01-17 holding as of filing | Casey Mark J Officer (Sr. VP, General Counsel) | 3 | Non-Qualified Stock Option (right to buy) Derivative · Direct | Holding | $36.93 exercise price | 2008-01-17 | ||
| 2008-01-16 | CUMMING JOHN W Director, Officer (Chief Executive Officer) | 4/A | Non-Qualified Stock Option Derivative · Direct · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $66.62 exercise price | 2009-11-13 | |
| 2008-01-16 | CUMMING JOHN W Director, Officer (Chief Executive Officer) | 4/A | Non-Qualified Stock Option Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $66.62 exercise price | 2009-11-13 | |
| 2008-01-16 | MUIR GLENN P Director, Officer (Executive VP and CFO) | 4 | Nonqualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $66.62 exercise price | 2008-01-18 | |
| 2008-01-16 | SOLTANI PETER Officer (VP, BREAST IMAGING BUSINESS) | 4 | Nonqualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,000 22,000 owned after | $66.62 exercise price | 2008-01-18 | |
| 2008-01-16 | LAVALLEE ROBERT H Officer (SENIOR VP & CHIEF ACCT OFFICER) | 4 | Nonqualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,000 22,000 owned after | $66.62 exercise price | 2008-01-18 | |
| 2008-01-16 | Kingsley Stuart A Officer (PRES., HOLOGIC GYN SURG. PROD.) | 4 | Nonqualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,000 22,000 owned after | $66.62 exercise price | 2008-01-18 | |
| 2008-01-16 | Casey Mark J Officer (Senior V.P & General Counsel) | 4 | Nonqualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $66.62 exercise price | 2008-01-18 | |
| 2008-01-16 | PEKARSKY JOHN R Officer (SR VP SALES & STRATEGIC ACCTS) | 4 | Nonqualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $66.62 exercise price | 2008-01-18 | |
| 2008-01-16 | STEIN JAY A Director, Officer (SENIOR VP/TECHNICAL DIRECTOR) | 4 | Nonqualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,000 22,000 owned after | $66.62 exercise price | 2008-01-18 | |
| 2008-01-16 | Doran Howard JR Officer (PRESIDENT, DIAGNOSTICS) | 4 | Nonqualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,000 22,000 owned after | $66.62 exercise price | 2008-01-18 | |
| 2008-01-16 | CASCELLA ROBERT Officer (PRESIDENT & COO) | 4 | Nonqualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $66.62 exercise price | 2008-01-18 | |
| 2008-01-16 | CUMMING JOHN W Director, Officer (CHIEF EXECUTIVE OFFICER) | 4 | Nonqualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $66.62 exercise price | 2008-01-18 | |
| 2008-01-16 holding as of filing | Kingsley Stuart A Officer (Pres.,Hologic Gyn Surg. Prod.) | 3/A | Incentive Stock Option Derivative · Direct | Holding | $31.10 exercise price | 2008-01-16 | ||
| 2008-01-16 holding as of filing | Kingsley Stuart A Officer (Pres.,Hologic Gyn Surg. Prod.) | 3/A | Nonqualified Stock Option Derivative · Direct | Holding | $31.10 exercise price | 2008-01-16 | ||
| 2008-01-16 holding as of filing | Kingsley Stuart A Officer (Pres.,Hologic Gyn Surg. Prod.) | 3/A | Incentive Stock Option Derivative · Direct | Holding | $36.64 exercise price | 2008-01-16 | ||
| 2008-01-16 holding as of filing | Kingsley Stuart A Officer (Pres.,Hologic Gyn Surg. Prod.) | 3/A | Nonqualified Stock Option Derivative · Direct | Holding | $36.64 exercise price | 2008-01-16 | ||
| 2008-01-16 holding as of filing | Doran Howard JR Officer (Pres.,Hologic Diagnostic Prod.) | 3/A | Nonqualified Stock Option Derivative · Direct | Holding | $16.46 exercise price | 2008-01-16 | ||
| 2008-01-16 holding as of filing | Doran Howard JR Officer (Pres.,Hologic Diagnostic Prod.) | 3/A | Nonqualified Stock Option Derivative · Direct | Holding | $34.55 exercise price | 2008-01-16 | ||
| 2008-01-16 holding as of filing | Doran Howard JR Officer (Pres.,Hologic Diagnostic Prod.) | 3/A | Incentive Stock Option Derivative · Direct | Holding | $34.55 exercise price | 2008-01-16 | ||
| 2008-01-16 holding as of filing | Doran Howard JR Officer (Pres.,Hologic Diagnostic Prod.) | 3/A | Incentive Stock Option Derivative · Direct | Holding | $31.62 exercise price | 2008-01-16 | ||
| 2008-01-16 holding as of filing | Doran Howard JR Officer (Pres.,Hologic Diagnostic Prod.) | 3/A | Nonqualified Stock Option Derivative · Direct | Holding | $31.62 exercise price | 2008-01-16 | ||
| 2008-01-16 holding as of filing | Doran Howard JR Officer (Pres.,Hologic Diagnostic Prod.) | 3/A | Incentive Stock Option Derivative · Direct | Holding | $36.93 exercise price | 2008-01-16 | ||
| 2008-01-16 holding as of filing | Doran Howard JR Officer (Pres.,Hologic Diagnostic Prod.) | 3/A | Nonqualified Stock Option Derivative · Direct | Holding | $36.93 exercise price | 2008-01-16 | ||
| 2008-01-16 holding as of filing | Doran Howard JR Officer (Pres.,Hologic Diagnostic Prod.) | 3/A | Incentive Stock Option Derivative · Direct | Holding | $36.60 exercise price | 2008-01-16 | ||
| 2008-01-16 holding as of filing | Doran Howard JR Officer (Pres.,Hologic Diagnostic Prod.) | 3/A | Nonqualified Stock Option Derivative · Direct | Holding | $36.60 exercise price | 2008-01-16 | ||
| 2008-01-07 | Lerner Arthur G Director | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 0 owned after | $18.48 exercise price | 2008-01-08 | |
| 2008-01-07 | Lerner Arthur G Director | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 0 owned after | $37.92 exercise price | 2008-01-08 | |
| 2008-01-07 | Lerner Arthur G Director | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,000 0 owned after | $47.28 exercise price | 2008-01-08 | |
| 2008-01-04 | WILSON WAYNE Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 0 owned after | $16.46 exercise price | 2008-01-08 | |
| 2008-01-04 | CRAWFORD SALLY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −360 0 owned after | $25.28 exercise price | 2008-01-08 | |
| 2008-01-04 | CRAWFORD SALLY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,600 23,000 owned after | $26.99 exercise price | 2008-01-08 | |
| 2008-01-03 | Fajardo Laurie Director | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 4,000 owned after | $47.28 exercise price | 2008-01-03 |